Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New site added to international phase II study of Litx

Dec. 9, 2003

Treatment commences in pivotal European phase II trial of clofarabine for ALL

Dec. 9, 2003

Allos completes RSR-13 NDA filing

Dec. 9, 2003

CC-5079 induces NF-B-independent apoptosis of hematopoietic cancer cells

Dec. 9, 2003

Potent in vitro effects of OSW-1 against human leukemia cells

Dec. 9, 2003

Enhanced apoptosis with LAQ-824 and Apo2L/TRAIL cotreatment

Dec. 9, 2003

CGP-76030 inhibits proliferation of imatinib-resistant, Bcr/Abl-transformed murine bone marrow cells

Dec. 9, 2003

Phase I study evaluates oral clofarabine in solid tumors

Dec. 5, 2003

Protein farnesyltransferase inhibitor R-115777 assessed in breast cancer model

Dec. 5, 2003

Preliminary phase II results reported for vinflunine in metastatic breast cancer

Dec. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...